Audit 292127

FY End
2023-05-31
Total Expended
$21.29M
Findings
2
Programs
4
Organization: Owensboro Health, Inc. (KY)
Year: 2023 Accepted: 2024-02-26
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
370511 2023-001 Significant Deficiency Yes L
946953 2023-001 Significant Deficiency Yes L

Contacts

Name Title Type
LA1GP45KRC79 Russ Ranallo Auditee
2706857180 Jennifer Turk Dilibero Auditor
No contacts on file

Notes to SEFA

Title: Summary of Significant Accounting Policies Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) is presented using the accrual basis of accounting and summarizes the expenditures of Owensboro Health, Inc. and affiliated entities (the System) under programs of the federal government for the year ended May 31, 2023. Because the Schedule presents only a selected portion of the operations of the System, it is not intended to, and does not, present the financial position, results of operations, changes in net assets, and cash flows of the System. For purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between the System, the agencies and departments of the federal government, and all subawards to the System by nonfederal organizations pursuant to federal grants, contracts, and similar agreements. The information in the Schedule is presented in accordance with the provisions of the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The System has not elected to use the 10% de minimis indirect cost rate as permitted under the Uniform Guidance, Section 200.414. Basis of Presentation and Accounting The accompanying Schedule of Expenditures of Federal Awards (the Schedule) is presented using the accrual basis of accounting and summarizes the expenditures of Owensboro Health, Inc. and affiliated entities (the System) under programs of the federal government for the year ended May 31, 2023. Because the Schedule presents only a selected portion of the operations of the System, it is not intended to, and does not, present the financial position, results of operations, changes in net assets, and cash flows of the System. For purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between the System, the agencies and departments of the federal government, and all subawards to the System by nonfederal organizations pursuant to federal grants, contracts, and similar agreements. The information in the Schedule is presented in accordance with the provisions of the Uniform Guidance. The System has not elected to use the 10% de minimis indirect cost rate as permitted under the Uniform Guidance, Section 200.414.
Title: Provider Relief Fund Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) is presented using the accrual basis of accounting and summarizes the expenditures of Owensboro Health, Inc. and affiliated entities (the System) under programs of the federal government for the year ended May 31, 2023. Because the Schedule presents only a selected portion of the operations of the System, it is not intended to, and does not, present the financial position, results of operations, changes in net assets, and cash flows of the System. For purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between the System, the agencies and departments of the federal government, and all subawards to the System by nonfederal organizations pursuant to federal grants, contracts, and similar agreements. The information in the Schedule is presented in accordance with the provisions of the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The System has not elected to use the 10% de minimis indirect cost rate as permitted under the Uniform Guidance, Section 200.414. As required by the granting agency, the Provider Relief Fund (PRF) amounts presented in the Schedule represent lost revenues and expenses as reported to the U.S. Department of Health and Human Services for the PRF Portal Reporting Time Periods of July 1, 2022 to September 30, 2022 and January 1, 2023 to March 31, 2023.

Finding Details

Finding 2023-001 – Reporting Federal Program: COVID-19 Provider Relief Fund ALN: 93.498 Federal Agency: U.S. Department of Health and Human Services Federal Award Years: July 1, 2022 through September 30, 2022 Criteria: 45 CFR section 75.303 (a) states non-federal entities must: Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government,” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework,” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). 45 CFR section 75.303 (b) states non-federal entities must: Comply with Federal statutes, regulations, and the terms and conditions of the Federal awards. Recipients of provider relief funds must support all expenses with adequate documentation and maintain proper control documentation to substantiate that these funds were used for health care-related expenses or lost revenues attributable to coronavirus. Condition Found, Including Perspective: There is no evidence of management’s review of reports submitted to the Health Resources and Services Administration (HRSA) reporting portal prior to their submission to the U.S. Department of Health and Human Services for the Period 3 reporting period. Possible Cause and Effect: While Owensboro Health, Inc. maintains that a management review did occur prior to submission, controls were not designed or implemented effectively to maintain evidence of management’s manual review. Such reviews occurred verbally over phone calls, online meeting platforms, and emails, which were not recorded or retained. A similar finding was communicated in the prior year subsequent to Owensboro Health, Inc. submitting its Period 3 portal reporting to HRSA. Owensboro Health, Inc. remediated the finding concurrent with its Period 4 portal reporting to HRSA. Questioned Costs: None. Statistical Validity: The sample was not intended to be, and was not, a statistically valid sample. Repeat Finding in the Prior Year: This is a repeat finding. Recommendation We recommend that management continue to monitor its design of management review controls to ensure that documentation of management reviews of federal reports is consistently maintained. Views of Responsible Officials: Owensboro Health, Inc. implemented controls and processes to ensure grant reports are reviewed prior to submission and that evidence of review is maintained. These controls and processes were in place for the Period 4 submission.
Finding 2023-001 – Reporting Federal Program: COVID-19 Provider Relief Fund ALN: 93.498 Federal Agency: U.S. Department of Health and Human Services Federal Award Years: July 1, 2022 through September 30, 2022 Criteria: 45 CFR section 75.303 (a) states non-federal entities must: Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government,” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework,” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). 45 CFR section 75.303 (b) states non-federal entities must: Comply with Federal statutes, regulations, and the terms and conditions of the Federal awards. Recipients of provider relief funds must support all expenses with adequate documentation and maintain proper control documentation to substantiate that these funds were used for health care-related expenses or lost revenues attributable to coronavirus. Condition Found, Including Perspective: There is no evidence of management’s review of reports submitted to the Health Resources and Services Administration (HRSA) reporting portal prior to their submission to the U.S. Department of Health and Human Services for the Period 3 reporting period. Possible Cause and Effect: While Owensboro Health, Inc. maintains that a management review did occur prior to submission, controls were not designed or implemented effectively to maintain evidence of management’s manual review. Such reviews occurred verbally over phone calls, online meeting platforms, and emails, which were not recorded or retained. A similar finding was communicated in the prior year subsequent to Owensboro Health, Inc. submitting its Period 3 portal reporting to HRSA. Owensboro Health, Inc. remediated the finding concurrent with its Period 4 portal reporting to HRSA. Questioned Costs: None. Statistical Validity: The sample was not intended to be, and was not, a statistically valid sample. Repeat Finding in the Prior Year: This is a repeat finding. Recommendation We recommend that management continue to monitor its design of management review controls to ensure that documentation of management reviews of federal reports is consistently maintained. Views of Responsible Officials: Owensboro Health, Inc. implemented controls and processes to ensure grant reports are reviewed prior to submission and that evidence of review is maintained. These controls and processes were in place for the Period 4 submission.